1). Javazon EH., Beggs KJ., Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004. 32:414–25.
Article
2). Kortesidis A., Zannettino A., Isenmann S., Shi S., La-pidot T., Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005. 105:3793–801.
Article
3). Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek AM., Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006. 24:1030–41.
Article
4). Sordi V., Malosio ML., Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005. 106:419–27.
Article
5). Psenak O., Sefc L., Sykora V., Chang KT., Necas E. Cytokine gene expression in regenerating haematopoietic tissues of mice after cyclophosphamide treatment. Acta Haematol. 2003. 109:68–75.
Article
6). Bromley SK., Peterson DA., Gunn MD., Dustin ML. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol. 2000. 165:15–9.
Article
7). Gentilini G., Kirschbaum NE., Augustine JA., Aster RH., Visentin GP. Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21 (Cip1/WAF1). Blood. 1999. 93:25–33.
8). Luster AD., Greenberg SM., Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med. 1995. 182:219–31.
Article
9). Sanchez X., Suetomi K., Cousins-Hodges B., Horton JK., Navarro J. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2. J Immunol. 1998. 160:906–10.
10). Huang Z. Structure, function and modulation of chemokine receptors: members of the g-protein-coupled receptor superfamily. Mini Rev Med Chem. 2002. 2:373–83.
Article
11). Reisine T. Pertussis toxin in the analysis of receptor mechanisms. Biochem Pharmacol. 1990. 39:1499–504.
Article
12). Kaslow HR., Burns DL. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 1992. 6:2684–90.
Article
13). Nishi N., Ishikawa R., Inoue H, et al. In vitro longterm culture of human primitive hematopoietic cells supported by murine stromal cell line MS-5. Leukemia. 1997. 11(Suppl 3):468–73.
14). Kim CH., Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998. 91:100–10.
Article
15). Rickard DJ., Kassem M., Hefferan TE., Sarkar G., Spel-sberg TC., Riggs BL. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res. 1996. 11:312–24.
Article
16). Stenderup K., Justesen J., Clausen C., Kassem M. A-ging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003. 33:919–26.
Article
17). Reyes M., Lund T., Lenvik T., Aguiar D., Koodie L., Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001. 98:2615–25.
Article
18). Lodie TA., Blickarz CE., Devarakonda TJ, et al. Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction. Tissue Eng. 2002. 8:739–51.
Article
19). Bonig H., Rohmer L., Papayannopoulou T. Longterm functional impairment of hemopoietic progenitor cells engineered to express the S1 catalytic subunit of pertussis toxin. Exp Hematol. 2005. 33:689–98.
Article
20). He YX., Hewlett E., Temeles D., Quesenberry P. Inhibition of interleukin 3 and colony-stimulating factor 1-stimulated marrow cell proliferation by pertussis toxin. Blood. 1988. 71:1187–95.
Article
21). Papayannopoulou T., Priestley GV., Bonig H., Naka-moto B. The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization. Blood. 2003. 101:4739–47.
Article
22). Hinds PW 2nd., Yin C., Salvato MS., Pauza CD. Pertussis toxin induces lymphocytosis in rhesus macaques. J Med Primatol. 1996. 25:375–81.
Article
23). Neel NF., Schutyser E., Sai J., Fan GH., Richmond A. Chemokine receptor internalization and intracellular trafficking. Cytokine Growth Factor Rev. 2005. 16:637–58.
Article
24). Juarez J., Bendall L., Bradstock K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des. 2004. 10:1245–59.
25). Lee Y., Gotoh A., Kwon HJ, et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood. 2002. 99:4307–17.
Article